Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 131

    1.

    Molecular dynamics simulation of human LOX-1 provides an explanation for the lack of OxLDL binding to the Trp150Ala mutant.

    Falconi M, Biocca S, Novelli G, Desideri A.

    BMC Struct Biol. 2007 Nov 7;7:73.PMID: 17988382 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Crystal structure of human lectin-like, oxidized low-density lipoprotein receptor 1 ligand binding domain and its ligand recognition mode to OxLDL.

    Ohki I, Ishigaki T, Oyama T, Matsunaga S, Xie Q, Ohnishi-Kameyama M, Murata T, Tsuchiya D, Machida S, Morikawa K, Tate S.

    Structure. 2005 Jun;13(6):905-17.PMID: 15939022 [PubMed - indexed for MEDLINE]Related articles

    3.

    Requirements of basic amino acid residues within the lectin-like domain of LOX-1 for the binding of oxidized low-density lipoprotein.

    Chen M, Inoue K, Narumiya S, Masaki T, Sawamura T.

    FEBS Lett. 2001 Jun 22;499(3):215-9.PMID: 11423119 [PubMed - indexed for MEDLINE]Related articles

    4.

    Chimeric structural stabilities in the coiled-coil structure of the NECK domain in human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1).

    Ishigaki T, Ohki I, Utsunomiya-Tate N, Tate SI.

    J Biochem. 2007 Jun;141(6):855-66. Epub 2007 Apr 6.PMID: 17416594 [PubMed - indexed for MEDLINE]Related articles

    5.

    CRP is a novel ligand for the oxidized LDL receptor LOX-1.

    Shih HH, Zhang S, Cao W, Hahn A, Wang J, Paulsen JE, Harnish DC.

    Am J Physiol Heart Circ Physiol. 2009 May;296(5):H1643-50. Epub 2009 Feb 27.PMID: 19252093 [PubMed - indexed for MEDLINE]Related articles

    6.

    Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding.

    Chen M, Narumiya S, Masaki T, Sawamura T.

    Biochem J. 2001 Apr 15;355(Pt 2):289-96.PMID: 11284714 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Functional analysis and molecular dynamics simulation of LOX-1 K167N polymorphism reveal alteration of receptor activity.

    Biocca S, Falconi M, Filesi I, Baldini F, Vecchione L, Mango R, Romeo F, Federici G, Desideri A, Novelli G.

    PLoS One. 2009;4(2):e4648. Epub 2009 Feb 27.PMID: 19247493 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Purification, crystallization and preliminary X-ray analysis of the ligand-binding domain of human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1).

    Ishigaki T, Ohki I, Oyama T, Machida S, Morikawa K, Tate S.

    Acta Crystallogr Sect F Struct Biol Cryst Commun. 2005 May 1;61(Pt 5):524-7. Epub 2005 Apr 28.PMID: 16511086 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The LOX-1 scavenger receptor cytoplasmic domain contains a transplantable endocytic motif.

    Vohra RS, Walker JH, Howell GJ, Homer-Vanniasinkam S, Ponnambalam S.

    Biochem Biophys Res Commun. 2009 May 29;383(2):269-74. Epub 2009 Apr 7.PMID: 19358829 [PubMed - indexed for MEDLINE]Related articles

    10.

    Dominant-negative lox-1 blocks homodimerization of wild-type lox-1-induced cell proliferation through extracellular signal regulated kinase 1/2 activation.

    Tanigawa H, Miura S, Matsuo Y, Fujino M, Sawamura T, Saku K.

    Hypertension. 2006 Aug;48(2):294-300. Epub 2006 Jul 3.PMID: 16818807 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) in atherogenesis: a brief review.

    Reiss AB, Anwar K, Wirkowski P.

    Curr Med Chem. 2009;16(21):2641-52. Review.PMID: 19601801 [PubMed - indexed for MEDLINE]Related articles

    12.

    The 1.4 angstrom crystal structure of the human oxidized low density lipoprotein receptor lox-1.

    Park H, Adsit FG, Boyington JC.

    J Biol Chem. 2005 Apr 8;280(14):13593-9. Epub 2005 Feb 5.PMID: 15695803 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The hydrophobic tunnel present in LOX-1 is essential for oxidized LDL recognition and binding.

    Francone OL, Tu M, Royer LJ, Zhu J, Stevens K, Oleynek JJ, Lin Z, Shelley L, Sand T, Luo Y, Kane CD.

    J Lipid Res. 2009 Mar;50(3):546-55. Epub 2008 Oct 9.PMID: 18845619 [PubMed - indexed for MEDLINE]Related articles

    14.

    Oligomerization is required for the activity of recombinant soluble LOX-1.

    Cao W, Calabro V, Root A, Yan G, Lam K, Olland S, Sanford J, Robak A, Zollner R, Lu Z, Ait-Zahra M, Agostinelli R, Tchistiakova L, Gill D, Harnish D, Paulsen J, Shih HH.

    FEBS J. 2009 Sep;276(17):4909-20. Epub 2009 Jul 31.PMID: 19664054 [PubMed - indexed for MEDLINE]Related articles

    15.

    Functional refolding of a recombinant C-type lectin-like domain containing intramolecular disulfide bonds.

    Vohra RS, Murphy JE, Walker JH, Homer-Vanniasinkam S, Ponnambalam S.

    Protein Expr Purif. 2007 Apr;52(2):415-21. Epub 2006 Dec 1.PMID: 17196395 [PubMed - indexed for MEDLINE]Related articles

    16.

    Lectin-like oxidized low-density lipoprotein receptor-1-mediated autophagy in human granulosa cells as an alternative of programmed cell death.

    Duerrschmidt N, Zabirnyk O, Nowicki M, Ricken A, Hmeidan FA, Blumenauer V, Borlak J, Spanel-Borowski K.

    Endocrinology. 2006 Aug;147(8):3851-60. Epub 2006 May 11.PMID: 16690797 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The splice variant LOXIN inhibits LOX-1 receptor function through hetero-oligomerization.

    Biocca S, Filesi I, Mango R, Maggiore L, Baldini F, Vecchione L, Viola A, Citro G, Federici G, Romeo F, Novelli G.

    J Mol Cell Cardiol. 2008 Mar;44(3):561-70. Epub 2007 Dec 7.PMID: 18191942 [PubMed - indexed for MEDLINE]Related articles

    18.

    Essential role of cytoplasmic sequences for cell-surface sorting of the lectin-like oxidized LDL receptor-1 (LOX-1).

    Chen M, Sawamura T.

    J Mol Cell Cardiol. 2005 Sep;39(3):553-61.PMID: 15935375 [PubMed - indexed for MEDLINE]Related articles

    19.

    Oxidised LDL internalisation by the LOX-1 scavenger receptor is dependent on a novel cytoplasmic motif and is regulated by dynamin-2.

    Murphy JE, Vohra RS, Dunn S, Holloway ZG, Monaco AP, Homer-Vanniasinkam S, Walker JH, Ponnambalam S.

    J Cell Sci. 2008 Jul 1;121(Pt 13):2136-47. Epub 2008 Jun 10.PMID: 18544637 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis.

    Ishigaki Y, Katagiri H, Gao J, Yamada T, Imai J, Uno K, Hasegawa Y, Kaneko K, Ogihara T, Ishihara H, Sato Y, Takikawa K, Nishimichi N, Matsuda H, Sawamura T, Oka Y.

    Circulation. 2008 Jul 1;118(1):75-83. Epub 2008 Jun 16.PMID: 18559699 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination